Prashant V Bommi

6PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

|Feb 13, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC).

Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu

|Sep 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.

Margaret Johnson, April Bell, Kristen L Lauing

|Jul 16, 2021
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.

Charles M Bowen, Lewins Walter, Ester Borras

|May 18, 2021
The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.

Prashant V Bommi, Charles M Bowen, Laura Reyes-Uribe

|Nov 20, 2019
NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Prashant V Bommi, Vaibhav Chand, Nishit K Mukhopadhyay

Pageof 1

Frequent Collaborators

3 joint publications

Manon Penco-Campillo

3 joint publications

Derek A Wainwright

2 joint publications

Craig Horbinski

2 joint publications

Gary E Schiltz